IN THE NEWS: Biomarker Launches GeneEssence DNA Test:
SAN JOSE, Calif. March 31, 2008 BioMarker Pharmaceuticals, Inc., a privately-held company, announced today that it has officially launched and has begun offering its Gene Essence test directly to consumers in the United States. Based on recent advances in DNA analysis technology, the Gene Essence test provides customers with personalized genetic information that is unique to each individual. Please see www.geneessence.com to learn more.

YOUR PARTNER for a Healthier, Longer Life
At BioMarker our vision is to provide interventions that will extend a healthy human lifespan by slowing the process of aging, and delaying the onset of age-related diseases.
We are using genomic and proteomic aging-intervention technologies to accomplish this, and we invite you to learn more about our efforts in the following pages. These are the areas we are working in:

NUTRACEUTICALS: HEALTH MAINTENANCE PRODUCTS Using our aging-intervention technologies, we are designing dietary supplements focused upon age-related health maintenance, and moving forward immediately to bring scientifically proven and clinically validated products to market. >>Learn more
DIAGNOSTICS: PERSONALIZED HEALTH ASSESSMENT SERVICES Our aging-intervention biomarkers allow us to develop new risk assessment and diagnostic tools needed to provide people with personalized health-maintenance interventions. >>Learn more
THERAPEUTICS: TREATMENTS FOR AGE-RELATED DISEASE As aging-intervention technology matures, our screening systems will allow us to develop pharmaceutical products targeted to a variety of age-related diseases.>>Learn more